|
|
PERPUSTAKAAN SEKOLAH TINGGI ILMU KESEHATAN SAMARINDA REPOSITORY
|
|
Select Language
Simple Search
Advanced Search
License
This Software is Released Under GNU GPL License
Version 3.
indexed
Visitors
Statistic
|
| Title |
European Journal of Pharmaceutical Sciences 1 May 2025 |
| Edition |
1 May 2025 |
| Call Number |
|
| ISBN/ISSN |
|
| Author(s) |
|
| Subject(s) |
Cannabidiol Transdermal drug delivery Cannabis policies
|
| Classification |
|
| Series Title |
|
GMD |
Jurnal |
| Language |
Indonesia |
| Publisher |
|
| Publishing Year |
2025 |
| Publishing Place |
|
| Collation |
|
| Abstract/Notes |
ABSTRACT
Cannabidiol (CBD), one of the main actives from Cannabis sativa has been perpetually explored lately for its
therapeutic effects. Its main attributes, such as anti-inflammatory and antioxidant effects, snowball into pain
management, epilepsy and seizure alleviation, anxiety relief, as well as numerous other implications through the
entire metabolism. However, conventional administration routes challenge its therapeutic potential, with re-
ported poor water solubility, hepatic degradation, gastric instability and erratic bioavailability observed in oral
administration. As a result, the transdermal delivery systems have emerged as a promising alternative to oral or
inhaled routes, offering improved bioavailability and targeted effects. The medical use of CBD throughout
Europe, UK, USA or Australia is extensive and usually represented by pharmaceutical preparations recommended
after conventional treatment routs fail. The non-medical use is limited by each country’s own legislation, a wider
range of products being available, but the irregular regulatory landscape coupled with the growing market of
cannabinoid-infused products, emphasizes the need for standardized formulations and further clinical research.
The present work critically examines the transdermal administration of cannabidiol, explores the skin’s potential
as a route and the strategies involved in using it for systemic targeting. We highlighted key challenges and
provided insights into CBD`s variable bioavailability based on different administration routes and methods, thus
compiling a literature-based absorption, distribution, metabolism, and excretion (ADME) study. We also explore
the role of the endocannabinoid system, its function in various medical conditions, and the therapeutic effects
associated with CBD, particularly in light of the varying legislation across countries. While the breadth of po-tential benefits is compelling, it is essential to emphasize the ongoing nature of CBD research as individual re-sponses to it can vary significantly. |
| Specific Detail Info |
|
| Image |
 |
| File Attachment |
LOADING LIST... |
| Availability |
LOADING LIST... |
| |
Back To Previous |
|